Bicara Therapeutics | 10-Q: Quarterly report
Bicara Therapeutics | 8-K: Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Bicara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Raymond Debbane(5.7%),Invus Public Equities, L.P.(5.6%), etc.
Bicara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Red Tree Venture Fund, L.P.(5.8%),Red Tree GP, LLC(5.8%), etc.
Bicara Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(12.8%),Peter Kolchinsky(12.8%), etc.
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Bicara Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-TPG GP A, LLC(5.5%),David Bonderman(5.5%), etc.
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities- TPG GP A, LLC
Bicara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(5.095%),Abigail P. Johnson(5.095%)
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities- FIL Ltd
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities- FMR LLC
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Flynn James E
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LONBERG NILS
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simson Jake
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Biocon Ltd
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Haviland Kate
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mazumdar-Shaw Kiran
Bicara Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Robertson Scott M.
Bicara Therapeutics | 8-K: Current report
No Data